<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50114">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01703429</url>
  </required_header>
  <id_info>
    <org_study_id>BU-11A-1296</org_study_id>
    <nct_id>NCT01703429</nct_id>
  </id_info>
  <brief_title>Complementary and Alternative Care in Multiple Sclerosis</brief_title>
  <acronym>CAM Care in MS</acronym>
  <official_title>Complementary and Alternative Medicine (CAM) in Multiple Sclerosis. A Prospective Observational Study of a CAM-using Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bastyr University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bastyr University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational study designed to describe disease progression, symptom
      change, quality of life, diet and lifestyle habits, and frequency of adverse events among
      patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM).
      In addition to describing the patterns of CAM use, this study will also identify and
      describe the positive deviants, those individuals with the highest quality of life and least
      amount of disease activity.  Positive deviants will be compared to controls in order to
      describe medication, diet, and lifestyle patterns associated with a lack of MS disease
      progression and high quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>&quot;CAM Therapies&quot; survey</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>This survey has been developed to identify the complementary and alternative therapies most commonly used by individuals with MS.  Results will be reported with descriptive statistics.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modified Expanded Disability Severity Score (EDSS)</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The EDSS will be used to capture disease severity and rates of progression in this cohort.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>PROMIS: Global Health</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>This outcome measure will be used to assess general health and well-being in this CAM using cohort.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Individuals with MS</arm_group_label>
    <description>Individuals who are using CAM therapies adjunctively or in lieu of conventional therapy (including, but not limited to, special diets, exercise, meditation, prayer, support groups, herbal therapies, counseling, etc.)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Any individual with multiple sclerosis is invited to participate.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of multiple sclerosis (including relapsing remitting MS, secondary
             progressive MS, primary progressive MS, clinically isolated syndromes (CIS),
             radiologically-isolated syndromes (RIS), possible MS, or probable MS.

          -  Age 18-100

        Exclusion Criteria:

          -  Inability to read/write in English

          -  Inability or unwillingness to complete survey every six (6) months. (~ 45 min)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurie K Mischley, ND</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bastyr University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bastyr University Clinical Research Center</name>
      <address>
        <city>Kenmore</city>
        <state>Washington</state>
        <zip>98028</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie K Mischley, ND</last_name>
      <phone>425-602-3306</phone>
      <email>neuroresearch@bastyr.edu</email>
    </contact>
    <contact_backup>
      <last_name>Marco F Vespignani, ND</last_name>
      <phone>425-602-3309</phone>
      <email>mvespignani@bastyr.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Laurie K Mischley, ND</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco F Vespignani, ND</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.bastyr.edu/research/studies/complementary-alternative-medicine-care-multiple-sclerosis</url>
    <description>Related Info</description>
  </link>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>October 8, 2012</lastchanged_date>
  <firstreceived_date>October 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bastyr University</investigator_affiliation>
    <investigator_full_name>Laurie Mischley</investigator_full_name>
    <investigator_title>Clinical Research Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Multiple Sclerosis</keyword>
  <keyword>MS</keyword>
  <keyword>Complementary and Alternative</keyword>
  <keyword>CAM</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
